WHO: 1 December 2012 – World AIDS Day 2012: Getting to Zero
Getting to Zero: Zero new HIV infections. Zero deaths from AIDS-related illness. Zero discrimination is the theme of World AIDS Day 2012. Given the spread of the epidemic today, getting to zero may sound difficult but significant progress is underway.
In 2011, 2.5 million people were newly infected with HIV. An estimated 1.7 million people died. That is 700,000 fewer new infections worldwide than ten years ago, and 600,000 fewer deaths than in 2005…
http://www.who.int/hiv/events/2012/world_aids_day/en/index.html
.
PEPFAR Blueprint: Creating an AIDS-Free Generation
U.S. Secretary of State Hillary Rodham Clinton unveiled the new PEPFAR Blueprint to correspond to this year’s World AIDS Day on December 1. The document’s vision statement notes: Scientific advances and their successful implementation have brought the world to a tipping point in the fight against AIDS. The United States believes that by making smart investments based on sound science, and a shared global responsibility, we can save millions of lives and achieve an AIDS-free generation.
http://www.pepfar.gov/documents/organization/201386.pdf
NIH Statement: World AIDS Day 2012
December 1, 2012
Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases; Jack Whitescarver, Ph.D., Director, NIH Office of AIDS Research; Francis S. Collins, M.D., Ph.D., NIH Director
Extract
The International AIDS Conference in Washington, D.C., this past summer energized HIV/AIDS researchers and focused on the potential benefits of broadly implementing scientifically proven HIV prevention and treatment tools. On World AIDS Day, the National Institutes of Health joins with our global partners to maintain this momentum toward a world without AIDS. As the world’s leading funder of HIV/AIDS research, NIH is vigorously pursuing promising research in therapeutics, prevention (including efforts to develop a vaccine), and work toward a cure, while also studying how best to deliver these interventions to people who need them.
NIH-funded researchers have contributed to the development of the more than 30 antiretroviral drugs and drug combinations currently available, which have saved millions of lives. Additionally, NIH partners with pharmaceutical companies to identify optimal treatment regimens. We continue to pursue the development of new antiretroviral drugs that are longer acting, simpler to use, and less toxic than currently available therapies.
NIH also supports studies on how to improve HIV treatment outcomes and how to manage and reduce the incidence of diseases and complications associated with long-term HIV disease and antiretroviral therapy…
http://www.nih.gov/news/health/nov2012/niaid-29.htm
Media Release: China and Global Fund Signal Strong Partnership
30 November 2012
Extract
China and the Global Fund to Fight AIDS, Tuberculosis and Malaria marked a new stage in their partnership today by drawing senior leaders together with health workers and civil society partners to celebrate the achievements and identify the challenges of joint action to prevent and treat HIV and AIDS.
On the occasion of World AIDS Day, Premier Wen Jiabao led the special gathering inside the headquarters of the central government in downtown Beijing and welcomed Gabriel Jaramillo, General Manager of the Global Fund, as a special guest.
“China and the Global Fund have been cooperating well in the fight against HIV and AIDS,” said Premier Wen. He pledged that China do more to fight the spread of AIDS, both by working with international organizations and by investing in anti-AIDS efforts within China.
Mr. Jaramillo praised China’s leadership in fighting HIV, as the country assumes a more prominent role in global health efforts. He cited China’s generosity and its willingness to help other countries, as well as its growing commitment to domestic initiatives, as an example for all nations to follow.
vaccines and global health :: ethics and policy 